4 Drug, Biotech Stocks Rising More Than 50% in 2025 With Room to Grow
MLYS, LYEL, NKTR and INSM rise more than 50% in 2025 as clinical wins, FDA approvals and M&A deals revive …
Real-time market intelligence across asset classes
Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.
Over the last 30 days, AI sentiment for TECH skewed neutral (200 of 459 scored calls).
AI-curated news influencing TECH price, sentiment, and trend
MLYS, LYEL, NKTR and INSM rise more than 50% in 2025 as clinical wins, FDA approvals and M&A deals revive …
Stock Market Today: The Dow Jones index wavered Wednesday after a surprise drop in jobless claims. Nvidia stock cleared an …
Apple said it will pause its plans for compliance with the new law in Texas but notes other age assurance …
Here is the full list of the agtech and food tech Startup Battlefield 200 selectees, along with a note on …
Janus Henderson Investors, an investment management company, released its third-quarter 2025 investor letter for its “Janus Henderson Global Technology and …
Janus Henderson Investors, an investment management company, released its third-quarter 2025 investor letter for its “Janus Henderson Global Technology and …
Multi-Provider AI Analysis